The success of platinum-based anticancer agents has motivated the exploration of novel
metal-based drugs for several decades, whereas problems such as drug-resistance and …

The present review article offers a detailed account of the design strategies employed for the
synthesis of nitrogen-containing anticancer agents. The results of different studies describe …

Platinum-based anticancer drugs are among the most widely used antineoplastics in clinical
settings. Their therapeutic applications and outcomes are, however, greatly hampered by …

A series of novel nickel (II) thiosemicarbazone complexes (1–4) have been prepared and
characterized by various spectral, analytical techniques and X-ray crystallography. Further …

Abstract Pt (dpb) Cl, Pt (Fdpb) Cl, Pt (F 2 dpb) Cl and Pt (dpb) I complexes are examined by
computational chemistry method in all aspects. Hartree-Fock (HF) and Density Functional …

Since the discovery of cisplatin, light activation has been employed as a strategy to switch
and improve the anticancer effects of platinum compounds. This contribution highlights …

Site-specific delivery and amenable activation of prodrugs are indispensible criteria for
designing novel anticancer agents. Platinum based drugs vanguard the chemotherapeutic …

Abstract The complexes [Pd (valp) 2 (imidazole) 2](1),[Pd (valp) 2 (pyrazine) 2](2)(valp is
sodium valproate) have been synthesized and characterized using IR, 1 H NMR, 13 C {1 H} …

Platinum (II) complexes [Pt (pap)(an-cat)](1) and [Pt (pap)(py-cat)](2) with 2-(phenylazo)
pyridine (pap), 4-[2-[(anthracen-9-ylmethylene) amino] ethyl] benzene-1, 2-diol (H2an-cat) …

A new kind of Ni (II) complex of the type,[Ni (PPh3)(L)](1),{where L= chemosensor
thiosemicarbazone= 2-(3-bromo-5-chloro-2-hydroxybenzylidene)-N-phenyhydrazine …